251 related articles for article (PubMed ID: 27631462)
21. The effect of neutropenia on the clinical pharmacokinetics of vancomycin in adults.
Bury D; Ter Heine R; van de Garde EMW; Nijziel MR; Grouls RJ; Deenen MJ
Eur J Clin Pharmacol; 2019 Jul; 75(7):921-928. PubMed ID: 30877327
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the Effectiveness of Dose Individualization to Achieve Therapeutic Vancomycin Concentrations.
Abulfathi AA; Chirehwa M; Rosenkranz B; Decloedt EH
J Clin Pharmacol; 2018 Sep; 58(9):1134-1139. PubMed ID: 29746714
[TBL] [Abstract][Full Text] [Related]
23. Are higher vancomycin doses needed in ventricle-external shunted patients?
Pujal M; Soy D; Codina C; Ribas J
Pharm World Sci; 2006 Aug; 28(4):215-21. PubMed ID: 17066239
[TBL] [Abstract][Full Text] [Related]
24. Importance of vancomycin loading doses in intermittent infusion regimens.
Šíma M; Hartinger J; Cikánková T; Slanař O
J Infect Chemother; 2018 Apr; 24(4):247-250. PubMed ID: 29195829
[TBL] [Abstract][Full Text] [Related]
25. Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing Nomogram.
Yoon S; Park KR; Lee S; Song SH; Park WB; Jang IJ; Yu KS
Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):233-238. PubMed ID: 28834212
[TBL] [Abstract][Full Text] [Related]
26. Augmented Renal Clearance in Pediatric Patients With Febrile Neutropenia Associated With Vancomycin Clearance.
Hirai K; Ihara S; Kinae A; Ikegaya K; Suzuki M; Hirano K; Itoh K
Ther Drug Monit; 2016 Jun; 38(3):393-7. PubMed ID: 27172381
[TBL] [Abstract][Full Text] [Related]
27. [Therapeutic monitoring of intravenous vancomycin in a pediatric critical care unit].
Villena R; González CA; Nalegach ME; Vásquez A; Villareal M; Drago M
Rev Chilena Infectol; 2014 Jun; 31(3):249-53. PubMed ID: 25146197
[TBL] [Abstract][Full Text] [Related]
28. Vancomycin pharmacokinetic-pharmacodynamic parameters to optimize dosage administration in critically ill children.
Giachetto GA; Telechea HM; Speranza N; Oyarzun M; Nanni L; Menchaca A
Pediatr Crit Care Med; 2011 Nov; 12(6):e250-4. PubMed ID: 21057350
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of vancomycin and dosing recommendations for trauma patients.
Medellín-Garibay SE; Ortiz-Martín B; Rueda-Naharro A; García B; Romano-Moreno S; Barcia E
J Antimicrob Chemother; 2016 Feb; 71(2):471-9. PubMed ID: 26568565
[TBL] [Abstract][Full Text] [Related]
30. Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?
Heffernan AJ; Germano A; Sime FB; Roberts JA; Kimura E
Eur J Clin Pharmacol; 2019 Sep; 75(9):1219-1226. PubMed ID: 31154476
[TBL] [Abstract][Full Text] [Related]
31. [Correlation of pharmacokinetic parameters with serum vancomycin concentration in elderly patients with malignancies].
Sadoh S; Tsuji Y; Tsukamoto K
Yakugaku Zasshi; 2010 Jan; 130(1):69-73. PubMed ID: 20046068
[TBL] [Abstract][Full Text] [Related]
32. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.
Zhao W; Lopez E; Biran V; Durrmeyer X; Fakhoury M; Jacqz-Aigrain E
Arch Dis Child; 2013 Jun; 98(6):449-53. PubMed ID: 23254142
[TBL] [Abstract][Full Text] [Related]
33. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
[TBL] [Abstract][Full Text] [Related]
34. Population pharmacokinetic analysis of vancomycin in patients with hematological malignancies.
Buelga DS; del Mar Fernandez de Gatta M; Herrera EV; Dominguez-Gil A; García MJ
Antimicrob Agents Chemother; 2005 Dec; 49(12):4934-41. PubMed ID: 16304155
[TBL] [Abstract][Full Text] [Related]
35. Vancomycin dosing in children and young adults: back to the drawing board.
Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
[TBL] [Abstract][Full Text] [Related]
36. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
Waineo MF; Kuhn TC; Brown DL
J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
[TBL] [Abstract][Full Text] [Related]
37. Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline.
Marqués-Miñana MR; Saadeddin A; Peris JE
Br J Clin Pharmacol; 2010 Nov; 70(5):713-20. PubMed ID: 21039765
[TBL] [Abstract][Full Text] [Related]
38. Continuous intravenous vancomycin in children with normal renal function hospitalized in hematology-oncology: prospective validation of a dosing regimen optimizing steady-state concentration.
Hoegy D; Goutelle S; Garnier N; Rénard C; Faure-Conter C; Bergeron C; Bertrand Y; Bleyzac N
Fundam Clin Pharmacol; 2018 Jun; 32(3):323-329. PubMed ID: 29315849
[TBL] [Abstract][Full Text] [Related]
39. Influence of Mechanical Ventilation on the Pharmacokinetics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients.
Medellín-Garibay SE; Romano-Moreno S; Tejedor-Prado P; Rubio-Álvaro N; Rueda-Naharro A; Blasco-Navalpotro MA; García B; Barcia E
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893792
[TBL] [Abstract][Full Text] [Related]
40. Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis.
Decker BS; Kays MB; Chambers M; Kraus MA; Moe SM; Sowinski KM
Clin J Am Soc Nephrol; 2010 Nov; 5(11):1981-7. PubMed ID: 20616157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
